¹⁷⁷Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

Figure 6

Treatment response evaluated using the [^99mTc]Tc-iPSMA-SPECT diagnostic images (right and left, anterior and posterior images) after the therapy with ¹⁷⁷Lu-iPSMA (middle: anterior and posterior images at 24 h after the first cycle with ¹⁷⁷Lu-iPSMA) (patient 4, partial response).